CU Medicine Introduces Asia's First Histotripsy 2.0 System for Liver Tumour Treatment
The Chinese University of Hong Kong's Faculty of Medicine has received Asia's first Histotripsy 2.0 system, a donation from the Li Ka Shing Foundation, aimed at treating liver tumours. This advanced system, set to serve patients by early 2025, offers more precise focal therapy and supports continuous upgrades. The Foundation, along with CU Medicine and the Prince of Wales Hospital Charitable Foundation, will sponsor 30 patients to undergo this novel treatment, marking a significant step forward in cancer treatment research.
© Copyright 2025. All Rights Reserved by MedPath